Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 100751-100800 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04206319
Radium-223 in Biochemically Recurrent Prostate Cancer
PHASE2Recruiting
26 participants
Started: Sep 22, 2020 · Completed: Nov 15, 2027
1 condition1 sponsor1 location
NCT04563676
Physiopathology and Sequelae of COVID-19 Infection
NAActive, not recruiting
400 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04624698
iStent Inject New Enrollment Post-Approval Study
NAActive, not recruiting
358 participants
Started: Sep 22, 2020 · Completed: May 31, 2026
2 conditions1 sponsor3 locations
NCT05530642
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
NAActive, not recruiting
192 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2024
8 conditions13 sponsors1 location
NCT04539951
Pragmatic Trial of Obsessive-compulsive Disorder
PHASE2Recruiting
1,600 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2028
1 condition13 sponsors1 location
NCT04565067
Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans
N/AActive, not recruiting
83 participants
Started: Sep 22, 2020 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT04621916
Preventing Inhibitor Recurrence Indefinitely
PHASE4Active, not recruiting
52 participants
Started: Sep 21, 2020 · Completed: Apr 20, 2025
2 conditions2 sponsors1 location
NCT04596813
Role of Cytosorb in Left Ventricular Assist Device Implantation
NARecruiting
60 participants
Started: Sep 21, 2020 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT04447339
Open Nipple Sparing Mastectomy (NSM)
N/ARecruiting
75 participants
Started: Sep 21, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor5 locations
NCT04475666
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
NARecruiting
2,502 participants
Started: Sep 21, 2020 · Completed: Apr 30, 2026
2 conditions1 sponsor2 locations
NCT04623944
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
PHASE1Active, not recruiting
61 participants
Started: Sep 21, 2020 · Completed: Jul 31, 2039
4 conditions1 sponsor8 locations
NCT04298450
ED to EPI: Using SMS to Improve the Transition from the Emergency Department to Early Psychosis Intervention
NARecruiting
186 participants
Started: Sep 21, 2020 · Completed: Dec 31, 2025
11 conditions3 sponsors1 location
NCT04510220
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
PHASE3Recruiting
10 participants
Started: Sep 21, 2020 · Completed: Dec 31, 2021
1 condition2 sponsors1 location
NCT04564391
Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins
NARecruiting
80 participants
Started: Sep 21, 2020 · Completed: Jun 30, 2025
2 conditions4 sponsors1 location
NCT04615221
Immunological Mechanisms of Rejection in Uterine Transplantation
NARecruiting
30 participants
Started: Sep 21, 2020 · Completed: Sep 30, 2033
1 condition1 sponsor1 location
NCT04558450
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
NARecruiting
360 participants
Started: Sep 21, 2020 · Completed: Mar 31, 2033
4 conditions3 sponsors3 locations
NCT04166331
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
PHASE3Recruiting
270 participants
Started: Sep 20, 2020 · Completed: Dec 20, 2025
4 conditions2 sponsors27 locations
NCT06844942
Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve
N/ARecruiting
200 participants
Started: Sep 20, 2020 · Completed: Jan 31, 2029
4 conditions1 sponsor1 location
NCT04606732
CardioVascular Disease Progression and Prognosis in COVID-19
N/ARecruiting
2,000 participants
Started: Sep 20, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04555577
Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
PHASE1Recruiting
29 participants
Started: Sep 20, 2020 · Completed: Oct 30, 2025
2 conditions2 sponsors1 location
NCT05277857
Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome
N/ARecruiting
720 participants
Started: Sep 20, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06379152
Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction
N/ARecruiting
400 participants
Started: Sep 20, 2020 · Completed: Jul 1, 2024
2 conditions1 sponsor1 location
NCT06691880
Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke
NARecruiting
60 participants
Started: Sep 20, 2020 · Completed: Mar 20, 2026
2 conditions1 sponsor1 location
NCT04469491
Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study
PHASE2Active, not recruiting
74 participants
Started: Sep 20, 2020 · Completed: Sep 30, 2025
3 conditions12 sponsors7 locations
NCT04576143
Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer
PHASE2/PHASE3Recruiting
260 participants
Started: Sep 20, 2020 · Completed: Sep 20, 2027
2 conditions6 sponsors1 location
NCT04632901
A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
N/AActive, not recruiting
300 participants
Started: Sep 20, 2020 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT04546230
Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy.
NARecruiting
80 participants
Started: Sep 19, 2020 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04443322
Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )
NARecruiting
20 participants
Started: Sep 19, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04400331
Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease
PHASE3Active, not recruiting
154 participants
Started: Sep 18, 2020 · Completed: Mar 31, 2026
1 condition2 sponsors34 locations
NCT04547907
A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
PHASE3Recruiting
688 participants
Started: Sep 18, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04564781
Predicting BCG Response
N/ARecruiting
400 participants
Started: Sep 18, 2020 · Completed: Dec 30, 2027
1 condition6 sponsors5 locations
NCT04915235
Prevalence and Prognosis of Cardiac Amiloidosis in Turkey
N/ARecruiting
2,087 participants
Started: Sep 18, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04280718
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
PHASE2Active, not recruiting
229 participants
Started: Sep 18, 2020 · Completed: Apr 30, 2027
1 condition1 sponsor147 locations
NCT04970056
Pancreatic Cancer Early Detection Consortium
N/ARecruiting
10,000 participants
Started: Sep 18, 2020 · Completed: Dec 31, 2030
4 conditions1 sponsor60 locations
NCT03994510
SHame prOpensity in bOrderline Personality Disorder
NARecruiting
688 participants
Started: Sep 18, 2020 · Completed: Sep 30, 2031
1 condition2 sponsors1 location
NCT04454216
GSD VI and GSD IX Natural History
N/ARecruiting
400 participants
Started: Sep 18, 2020 · Completed: Jan 1, 2030
7 conditions1 sponsor1 location
NCT04377854
Prognostic Value of BNP in MCS - a 25 Year Follow up Study
N/ARecruiting
1,000 participants
Started: Sep 18, 2020 · Completed: Aug 1, 2045
4 conditions1 sponsor1 location
NCT04597944
Lanadelumab in Bradykinin Angioedema
N/ARecruiting
80 participants
Started: Sep 18, 2020 · Completed: Sep 30, 2025
1 condition1 sponsor2 locations
NCT04196244
Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function
PHASE4Recruiting
994 participants
Started: Sep 18, 2020 · Completed: Sep 30, 2033
2 conditions1 sponsor3 locations
NCT04563650
COVID-19 Serology and Immunosenescence
NAActive, not recruiting
98 participants
Started: Sep 18, 2020 · Completed: Nov 30, 2024
4 conditions1 sponsor1 location
NCT04370587
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
30 participants
Started: Sep 17, 2020 · Completed: Jan 10, 2027
6 conditions1 sponsor9 locations
NCT04447651
Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
N/AActive, not recruiting
6 participants
Started: Sep 17, 2020 · Completed: Aug 31, 2026
5 conditions4 sponsors1 location
NCT06221397
Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma
N/ARecruiting
200 participants
Started: Sep 17, 2020 · Completed: Sep 30, 2024
2 conditions5 sponsors1 location
NCT04443530
Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent in Routine Clinical Practice
N/ARecruiting
2,000 participants
Started: Sep 17, 2020 · Completed: Dec 31, 2030
1 condition2 sponsors11 locations
NCT05155722
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy with BAT1308 in Advanced Solid Tumors
PHASE1Active, not recruiting
148 participants
Started: Sep 17, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04533581
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)
PHASE2Active, not recruiting
61 participants
Started: Sep 17, 2020 · Completed: May 31, 2028
1 condition1 sponsor30 locations
NCT04545177
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
NAActive, not recruiting
18 participants
Started: Sep 17, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04464434
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
PHASE4Recruiting
50 participants
Started: Sep 17, 2020 · Completed: Oct 1, 2030
8 conditions4 sponsors12 locations
NCT03993106
A Study of sEphB4-HSA in Kaposi Sarcoma
PHASE2Recruiting
65 participants
Started: Sep 17, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor3 locations
NCT04358900
Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
N/AActive, not recruiting
132 participants
Started: Sep 17, 2020 · Completed: Nov 30, 2025
6 conditions2 sponsors1 location